340 results on '"Camera, Marina"'
Search Results
2. Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 2
3. Prospective, international, multisite comparison of platelet isolation techniques for genome-wide transcriptomics: communication from the SSC of the ISTH
4. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology
5. Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology
6. Consensus report on markers to distinguish procoagulant platelets from apoptotic platelets: communication from the Scientific and Standardization Committee of the ISTH
7. Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study
8. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity
9. Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study
10. PCSK9 promotes arterial medial calcification
11. The Coagulative Cascade
12. Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain
13. Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients
14. Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis
15. Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
16. Drug repurposing in cardiovascular diseases: Opportunity or hopeless dream?
17. Digital PCR for high sensitivity viral detection in false-negative SARS-CoV-2 patients
18. D-dimer is associated with arterial and venous coronary artery bypass graft occlusion
19. Head-to-Head Comparison of Tissue Factor-Dependent Procoagulant Potential of Small and Large Extracellular Vesicles in Healthy Subjects and in Patients with SARS-CoV-2 Infection
20. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y 12 and Link to Residual Platelet Reactivity
21. Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison?
22. Computational Design, Synthesis, and Biological Evaluation of Diimidazole Analogues Endowed with Dual PCSK9/HMG-CoAR-Inhibiting Activity
23. Patho- physiological role of BDNF in fibrin clotting
24. Biological profile of monocyte-derived macrophages in coronary heart disease patients: implications for plaque morphology
25. Chronic Kidney Disease in Acute Myocardial Infarction: Clinical Relevance and Novel Potential Fields of Investigation
26. Multi-center evaluation of light transmission platelet aggregation reagents: Communication from the ISTH SSC Subcommittee on Platelet Physiology
27. LDL lowering effect of PCSK9 inhibition is reduced in women
28. Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples
29. Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen
30. 823 MIGRAINE IN PFO PATIENTS: CHARACTERIZATION OF A PLATELET-ASSOCIATED PATHOPHYSIOLOGICAL MECHANISM BEFORE AND AFTER PFO CLOSURE: THE LEARNER STUDY
31. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity.
32. ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism
33. TCT-317 Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-associated Pathophysiological Mechanism. The LEARNER Study
34. Tissue Factor and Atherosclerosis: Not only vessel wall-derived TF, but also platelet-associated TF
35. Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
36. Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document
37. Letter by Brambilla et al Regarding Article, "Monocyte-Mediated Thrombosis Linked to Circulating Tissue-Factor and Immune Paralysis in COVID-19".
38. Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome
39. Different Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior
40. Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document
41. Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients
42. Influence of Atherogenic Lipoproteins on The Thrombotic Potential of Endothelial Cells
43. D-dimer is associated with arterial and venous coronary artery bypass graft occlusion
44. Proteome of platelets in patients with coronary artery disease
45. The Role of Tissue Factor in Atherothrombosis and Coronary Artery Disease: Insights into Platelet Tissue Factor
46. Tissue factor gene promoter haplotype associates with carotid intima-media thickness in subjects in cardiovascular risk prevention
47. Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain
48. Vitamin D and Cardiovascular Disease: Current Evidence and Future Perspectives
49. Patients with a history of stable or unstable coronary heart disease have different acute phase responses to an inflammatory stimulus
50. Alterations in platelets during SARS-CoV-2 infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.